Market & Alt Data
| Trade Date | Filed | Owner | Role | Type | Shares | Price | Value | Owned After | ||
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-10-22 | 2026-10-23 | Gheuens Sarah | Chief Medical Officer | Sale | 500 | $37.52 | $19K | 54.6K | View | |
| 2026-10-21 | 2026-10-23 | Gheuens Sarah | Chief Medical Officer | Sale | 1,489 | $37.53 | $56K | 54.6K | View | |
| 2026-08-04 | 2026-08-06 | Gheuens Sarah | Chief Medical Officer | Sale | 30.0K | $30.48 | $914K | 54.6K | View | |
| 2026-07-01 | 2026-07-02 | Gheuens Sarah | Chief Medical Officer | Sale | 4,007 | $37.56 | $151K | 84.6K | View | |
| 2026-04-02 | 2026-04-06 | Viswanadhan Krishnan | Chief Corp Dev & Strategy | Sale | 2,959 | $34.71 | $103K | 10.3K | View |
Informational purposes only, not investment advice.
tormere.com/research/AGIO · generated 2026-10-28
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 2026-10-22 | Gheuens Sarah | S | 500 | $18,760 |
| 2026-10-21 | Gheuens Sarah | S | 1,489 | $55,882.17 |
| 2026-08-04 | Gheuens Sarah | S | 30,000 | $914,400 |
| 2026-07-01 | Gheuens Sarah | S | 4,007 | $150,502.92 |
| 2026-04-02 | Viswanadhan Krishnan | S | 2,959 | $102,706.89 |
Tormere — informational purposes only, not investment advice.